Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fulgent Genetics Inc FLGT

Fulgent Genetics, Inc. is a technology-based genetic company with a laboratory services business and a therapeutic development business. The Company’s laboratory services business includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile (PK) profile of new and existing cancer drugs. Its technology platform for its laboratory services business includes gene probes, data suppression and comparison algorithms, learning software, and laboratory information management systems. The platform provides a test menu, the ability to rapidly develop and launch new tests and customizable test offerings. The Company also offers next-generation sequencing (NGS) services.


NDAQ:FLGT - Post by User

Post by Youhillmanon Oct 17, 2020 11:44am
175 Views
Post# 31734268

FLGT Outlook - Oracle Dispatch

FLGT Outlook - Oracle Dispatch

FYI.....shares are down a bit however only for the short term

Company Outlook

FLGT has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 0.76 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at 0.11. Fulgent Genetics Inc. FLGT also noted assets of $95.92 million at the end of the last quarter. Investors should also keep an eye on sector updates as FLGT has historically followed its peers on positive news. 

All told, Fulgent Genetics Inc. FLGT has strung together solid data and demonstrated underlying fundamentals. At its current valuation, FLGT represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels. 

Fulgent Genetics Inc. FLGT is now commanding a market cap of 860.73M and a float of 11.91M. FLGT is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of FLGT stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in FLGT, either long or short, and we have not been compensated for this article.

<< Previous
Bullboard Posts
Next >>